Xenon Pharmaceuticals (NasdaqGM:XENE) Update / Briefing December 10, 2025 10:00 AM ET Company ParticipantsIan Mortimer - President and CEOChris Kenney - Chief Medical OfficerDarren Cline - Chief Commercial OfficerIan MortimerGood morning, everyone, and thank you for joining us. We're excited to be speaking with you fresh off a highly successful American Epilepsy Society meeting for Xenon. Before we begin, please note the standard notice that we will make a number of statements today that are forward-looking ...